Long-Term Assets: The sum of all assets classified as non-current.
Phio Pharmaceuticals Corp. (PHIO) had Long-Term Assets of $0.00M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-7.15M |
|
-- |
|
-- |
|
$7.39M |
|
$-7.39M |
|
$0.24M |
|
$-7.15M |
|
$-7.15M |
|
$-7.15M |
|
$-7.15M |
|
$-7.15M |
|
$-7.15M |
|
$-7.39M |
|
$-7.38M |
|
0.79M |
|
0.79M |
|
$-9.08 |
|
$-9.08 |
|
| Balance Sheet Financials | |
$5.74M |
|
$0.00M |
|
|
Long-Term Assets |
$0.00M |
$5.74M |
|
$1.01M |
|
-- |
|
-- |
|
$1.01M |
|
$4.72M |
|
$4.72M |
|
$4.72M |
|
1.73M |
|
| Cash Flow Statement Financials | |
$-7.11M |
|
$0.01M |
|
$4.00M |
|
$8.49M |
|
$5.38M |
|
$-3.11M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-151.39% |
|
-151.39% |
|
-124.61% |
|
-151.39% |
|
$2.72 |
|
$-9.03 |
|
$-9.04 |
|